Increased incidence of localized osteonecrosis in the jaw bones caused by bisphosphanate use and reduced quality of life of the patients led researchers to diagnose the disease in the early period and to investigate the effective treatment modality. Treatment of medication-related osteonecrosis of the jaw patients is based on individual protocols from clinical experience, as there are no definitive treatment guidelines. In view of the lack of consensus on the effectiveness of medication-related osteonecrosis of the jaw treatments in the literature, the aim of this study was to evaluate the surgical technique described in the treatment of advanced stages of medication-related osteonecrosis of the jaw patients. Twenty-one patients affected by Stage 2-3 medication-related osteonecrosis of the jaw were treated with ultrasonic piezoelectric bone surgery for necrotic bone removing, leukocyte and platelet-rich fibrin concentrate obtained from the patient's peripheral blood and Nd:YAG laser for biostimulation. Success was assessed as the maintenance of full mucosal coverage without signs of residual infection at 1-month (T1), 3-months (T2), 6-months (T3) and 1-year (T4) after surgery. Logistic regressions were used to evaluate the association between the different independent variables and treatment outcomes. Two Stage 3 patients had delayed healing at 1 month after the operation. Complete mucosal healing was achieved in all patients at the third month. Multivariate analysis demonstrated that different variables were not significantly correlated with delayed healing (p > 0.05). The surgical protocol presented in this study shows promising results for surgical management of advanced stages of medication-related osteonecrosis of the jaw patients.
The aim of this study was to evaluate the effect of manual lymphatic drainage (MLD) on edema, pain and trismus after impacted mandibular third molar surgery. 46 patients with bilateral impacted mandibular third molar teeth were included in our study. The study was designed as a split-mouth, single-blinded, and controlled randomized clinical trial. Patients in the study group received MLD therapy, while the control group followed routine postoperative care including drug treatment. After extractions, the records were compared statistically and edema, pain and trismus parameters were evaluated on the 3rd and 7th days. The primary outcome variables was swelling and secondary outcome variables were pain and trismus. Swelling was evaluated using the 3dMD FACE SYSTEM (3dMD, Atlanta, GA). To assess pain, the Visual Analog Scale (VAS) was used and trismus was measured using with a digital caliper. The present study was conducted on a total of 46 patients, aged between 18 and 26 years (18.7174 ± 1.50056), with bilaterally similar, symmetrical impacted mandibular third molars. The group consisted of 14 males (30.4%) and 32 females (69.6%). Postoperative edema, pain and trismus were found to be significantly lower in the MLD group compared to the control group (p < 0.05). MLD technique is a useful method for reducing postoperative morbidity after impacted third molar extraction. The MLD technique is a simple method free from undesirable side effects and may be more effective than classical methods in reducing edema, pain and trismus after third molar extraction. The trial was registered retrospectively on ClinicalTrials.gov (ID: NCT06787027, on 22/01/2025). Approved by Izmir Katip Celebi University Clinical Research Ethics Committee (Decision No: ID 19, on 15/02/2018).